News & Updates

New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators

Research demonstrates the accuracy of Hyfe’s automated cough monitoring process and is the first to observe differences in type and length of cough between men and women.

Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management

AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.

Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection

Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.

Hyfe AI Announces New Remote Cough Monitoring Integration, Aiding to Reduce Patient Hospitalization and Improve Virtual Care

Studies show remote patient monitoring technology better predicts cough exacerbations to ultimately improve quality of life and reduce healthcare costs for patients with chronic cough.

Hyfe Announces Plans to Launch Digital Therapeutic for Chronic Coughers

Hyfe is expanding into chronic cough treatment with the world's first digital therapeutic for cough, using a proprietary model that combines real time cough frequency with cough suppression therapy.

Hyfe is Listed on CB Insights List of the Most Promising Digital Health Companies

150 winners selected out of 13,000 private companies; Hyfe recognized for contributions in screening, monitoring and diagnostics technologies

Hyfe Joins Forces with Merck to Deploy AI Cough-detection Technology

Hyfe has entered into an agreement with Merck, to integrate its artificial intelligence-powered (AI) cough tracker technology into Merck’s consumer disease educational efforts.

Press Release: Hyfe Deploys Artificial Intelligence-Powered Technology to Monitor, Screen and Diagnose Respiratory Illnesses

Leader in acoustic epidemiology empowers health care providers, researchers, pharmaceutical companies, and patients with cough detection and classification platform

Dr. Peter Small, Hyfe, Inc. Chief Medical Officer has Addressed the G20 meeting in Indonesia on the critical impact of digital innovation in combating Tuberculosis

Dr. Peter Small, Hyfe Chief Medical Officer has delivered deliver an intervention to the G20 Meeting in Yogyakarta, Indonesia, on the role of digital innovation in addressing public health crises.

Respiratory monitoring medtech firm appoints global expert as Chief Medical Officer

AI Medtech company Hyfe has announced the appointment of world-renowned Seattle-based physician and scientist Dr. Peter Small to the role of Chief Medical Officer.

Hyfe in the wall street journal: Coughs say a lot about your health, if your smartphone is listening

With apps and artificial intelligence, researchers want to use the cough to better diagnose asthma, Covid-19 and other respiratory illnesses

Hyfe Appoints Dr. Peter Small as Chief Medical Officer

Accomplished physician, scientist, and product developer to lead Hyfe's efforts as it seeks to transform patient care through cough monitoring and diagnosis.